AUPR120400A0 - New compound - Google Patents

New compound

Info

Publication number
AUPR120400A0
AUPR120400A0 AUPR1204A AUPR120400A AUPR120400A0 AU PR120400 A0 AUPR120400 A0 AU PR120400A0 AU PR1204 A AUPR1204 A AU PR1204A AU PR120400 A AUPR120400 A AU PR120400A AU PR120400 A0 AUPR120400 A0 AU PR120400A0
Authority
AU
Australia
Prior art keywords
new compound
compound
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR1204A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPR1204A priority Critical patent/AUPR120400A0/en
Publication of AUPR120400A0 publication Critical patent/AUPR120400A0/en
Priority to PCT/JP2001/009461 priority patent/WO2002036552A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPR1204A 2000-11-02 2000-11-02 New compound Abandoned AUPR120400A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AUPR1204A AUPR120400A0 (en) 2000-11-02 2000-11-02 New compound
PCT/JP2001/009461 WO2002036552A1 (en) 2000-11-02 2001-10-26 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR1204A AUPR120400A0 (en) 2000-11-02 2000-11-02 New compound

Publications (1)

Publication Number Publication Date
AUPR120400A0 true AUPR120400A0 (en) 2000-11-23

Family

ID=3825247

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR1204A Abandoned AUPR120400A0 (en) 2000-11-02 2000-11-02 New compound

Country Status (2)

Country Link
AU (1) AUPR120400A0 (en)
WO (1) WO2002036552A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5070797B2 (en) * 2005-12-08 2012-11-14 Jnc株式会社 Lateral oxirane compound and polymer thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2179286A5 (en) * 1972-04-05 1973-11-16 Honeywell Bull
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
AUPP549998A0 (en) * 1998-08-26 1998-09-17 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ575300A0 (en) * 2000-02-21 2000-03-16 Fujisawa Pharmaceutical Co., Ltd. New compound

Also Published As

Publication number Publication date
WO2002036552A1 (en) 2002-05-10
WO2002036552A8 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
AU2002225730A1 (en) Compounds
AU2002218266A1 (en) Novel indanylidene compounds
AU2000267458A1 (en) Hypercomputer
AU2001292518A1 (en) Novel compounds
AU2001266345A1 (en) Five-membered-ring compound
AU2001220246A1 (en) Neckphone
AUPP999799A0 (en) New compound
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001239765A1 (en) Novel compounds
AU2001246998A1 (en) Novel compounds
AUPR362001A0 (en) New compound
AU2001253362A1 (en) Novel compounds
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2002231077A1 (en) Novel compounds
AU2001254731A1 (en) Substituted phenyluracils
AU2001256964A1 (en) Novel compounds
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2002225724A1 (en) Motilide compounds
AU2002217285A1 (en) Compounds
AU2001230689A1 (en) Novel compounds
AU2002221923A1 (en) Novel compounds
AU2002216060A1 (en) Novel compounds
AU2001276890A1 (en) Novel compounds
AUPQ575300A0 (en) New compound